Overall, from the TCGA-LUAD database, survival analysis reflects conflicting trends, with Gehan's assay demonstrating a tumor suppressive phenotype of TNF (P = 0.025, Figure 1D) and TNFR2 (P = 0.07, Figure 1F), while log-rank's test shows a protumorigenic phenotype for TNFR1 (P = 0.03, Figure 1E). The gene discussed is TNFRSF1B; the disease is neoplasm.